Accessibility Tools
Invert colors
Monochrome
Dark contrast
Light contrast
Low saturation
High saturation
Highlight links
Highlight headings
Screen reader
Read mode
Content scaling
100
%
Font size
100
%
Line height
100
%
Letter spacing
100
%
(678) 384-7220
info@geovax.com
About Us
Company
Management
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA-VLP Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
News & Media
Contact
Contact Us
Careers
GeoVax Investor Information
SEC Filings
Group by
None
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
Search:
Clear filters
Year
All
2018
2019
2020
2021
2022
2023
Description
All
8-K
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Annual Report
Current Report
General Statement of Acquisition of Beneficial Ownership
Initial Ownership Report
Notice of Effectiveness
Other Definitive Proxy Statement
Other Definitive Proxy Statements
Other Preliminary Proxy Statement
Other Preliminary Proxy Statements
Post-Effective amendments for registration status
Preliminary Proxy Soliciting Materials
Prospectus
Prospectus Supplement
Quarterly Report
Registration Statement
Statement of Changes in Beneficial Ownership
Year
Date
Description
SEC Form
Download Word
Download Excel
Download PDF
(2)
No records
View
View
12-27
(1)
No records
2018
12-27
Current Report
8-K
View
01-22
(1)
No records
2019
01-22
Current Report
8-K
View
02-19
(1)
No records
2019
02-19
Other Preliminary Proxy Statements
PRE14A
View
02-19
(1)
No records
2019
02-19
8-K
Current Report
View
02-26
(1)
No records
2019
02-26
Current Report
8-K
View
02-27
(1)
No records
2019
02-27
Preliminary Proxy Soliciting Materials
PRER14A
View
03-01
(1)
No records
2019
03-01
Other Definitive Proxy Statements
DEF 14A
View
03-14
(1)
No records
2019
03-14
Other Definitive Proxy Statements
DEF 14A
View
About GeoVax
Company
Management
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Our Technology
Technology Overview
Publications
Investors
Corporate Profile
News
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
Product Pipeline
Pipeline Summary
Oncology
Infectious Diseases
SUBSCRIBE FOR UPDATES FROM GEOVAX
Register to receive email alerts for GeoVax press releases
SUBMIT
Email
Search
About Us
Company
Management
Board of Directors & Corporate Advisors
Scientific Advisory Board
Collaborators
Technology
MVA-VLP Technology Overview
Gedeptin® Technology Overview
Publications
Pipeline
Pipeline Summary
Oncology
Infectious Diseases
Investors
Corporate Profile
News
Events
SEC Filings
GeoVax Stock Information
Corporate Governance
Analyst Coverage
Investor FAQ's
News & Media
Contact
Contact Us
Careers